Add time:08/31/2019 Source:sciencedirect.com
BackgroundWe report our 10-year experience of a multicenter hemoglobin optimization program with the aim to reduce red blood cell transfusion in patients undergoing coronary artery bypass grafting (CABG).
We also recommend Trading Suppliers and Manufacturers of hemoglobin Nevers (cas 132822-83-4). Pls Click Website Link as below: cas 132822-83-4 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View